NEWS

NEWS 2021.6.23 Exhibiting at Arab Health 2021

Professor Hiroshi Kawamoto’s laboratory, Kyoto University, made an exhibition of its research a...

Media , NEWS 2021.6.9 Rebirthel’s research activity to develop a new T cell therapy for the novel coronavirus infection was introduced in the TV program “Hodo Station”

Professor Hiroshi Kawamoto, an executive director of Rebirthel and the Vice Director of Institu...

Media , NEWS 2021.5.18 Professor Hiroshi Kawamoto’s research was featured on Sankei Shimbun (Japanese newspaper)

In the evening edition of Sankei Shimbun on May 15th, 2021, Professor Hiroshi Kawamoto’s resear...

NEWS 2021.5.12 Professor Hiroshi Kawamoto was featured on the newsletter of Center for iPS Cell Research and Application, Kyoto University (CiRA) (Vol. 45, April 2021)

Center for iPS Cell Research and Application, Kyoto University (CiRA), where Nobel prize winner...

Media , NEWS 2021.4.27 Professor Hiroshi Kawamoto’s research was featured on Nihon Keizai Shimbun (Japanese newspaper)

In the morning edition of Nihon Keizai Shimbun on April 26th, 2021 (P. 9), a research activity ...

Media , NEWS 2021.4.9 Professor Hiroshi Kawamoto’s research was featured on Yomiuri Shimbun (Japanese newspaper)

In the morning edition of Yomiuri Shimbun on April 9th, 2021 (Science and medicine section, Pag...

NEWS 2021.4.1 Notice of relocation

Our office has moved to the following new address. Only the room number has been changed. There...

Media , NEWS 2021.2.15 Rebirthel was introduced on the web magazine “Nikkei Biotechnology & Business”

Nikkei Biotechnology & Business is the leading news site of biotechnology in Japan. In its ...